PKM and hepatocellular carcinoma: Several studies investigated that high expression of PKM2 is correlated with prognosis among several cancer patients such as breast cancer, hepatocellular carcinoma, esophageal squamous cell carcinoma, colorectal cancer, gallbladder cancer, and so on [20].